These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 9031740)

  • 1. In vivo receptor characterization of neuropeptide Y-induced effects in consecutive vascular sections of cat skeletal muscle.
    Ekelund U; Erlinge D
    Br J Pharmacol; 1997 Feb; 120(3):387-92. PubMed ID: 9031740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of glyceryl trinitrate, nitroprusside and nitric oxide on arterial, venous and capillary functions in cat skeletal muscle in vivo.
    Ekelund U
    Acta Physiol Scand; 1994 Sep; 152(1):93-105. PubMed ID: 7810336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neuropeptide Y (NPY) Y1 receptor antagonist BIBP 3226: equal effects on vascular responses to exogenous and endogenous NPY in the pig in vivo.
    Malmström RE; Balmér KC; Lundberg JM
    Br J Pharmacol; 1997 Jun; 121(3):595-603. PubMed ID: 9179405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA.
    Modin A; Malmström RE; Meister B
    Neuropeptides; 1999 Aug; 33(4):253-9. PubMed ID: 10657500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
    Malmström RE
    Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor subtypes Y1 and Y5 are involved in the renal effects of neuropeptide Y.
    Bischoff A; Avramidis P; Erdbrügger W; Münter K; Michel MC
    Br J Pharmacol; 1997 Apr; 120(7):1335-43. PubMed ID: 9105710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of angiotensin-converting enzyme inhibition on arterial, venous and capillary functions in cat skeletal muscle in vivo.
    Ekelund U
    Acta Physiol Scand; 1996 Sep; 158(1):29-37. PubMed ID: 8876745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasodilation in human subcutaneous arteries induced by neuropeptide Y is mediated by neuropeptide Y Y1 receptors and is nitric oxide dependent.
    Nilsson T; Lind H; Brunkvall J; Edvinsson L
    Can J Physiol Pharmacol; 2000 Mar; 78(3):251-5. PubMed ID: 10721817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vivo effects of endothelin-1 and ETA receptor blockade on arterial, venous and capillary functions in skeletal muscle.
    Ekelund U; Albert U; Edvinsson L; Mellander S
    Acta Physiol Scand; 1993 Jul; 148(3):273-83. PubMed ID: 8213182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo effects of endothelin-2, endothelin-3 and ETA receptor blockade on arterial, venous and capillary functions in cat skeletal muscle.
    Ekelund U
    Acta Physiol Scand; 1994 Jan; 150(1):47-56. PubMed ID: 8135123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of neuropeptide Y-induced feeding in mice: do Y1-Y6 receptor subtypes mediate feeding?
    Iyengar S; Li DL; Simmons RM
    J Pharmacol Exp Ther; 1999 May; 289(2):1031-40. PubMed ID: 10215684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A; Rägo L; Harro J
    Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergism between neuropeptide Y and norepinephrine highlights sympathetic cotransmission: studies in rat arterial mesenteric bed with neuropeptide Y, analogs, and BIBP 3226.
    Cortés V; Donoso MV; Brown N; Fanjul R; López C; Fournier A; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1313-22. PubMed ID: 10336522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries.
    You J; Edvinsson L; Bryan RM
    J Cereb Blood Flow Metab; 2001 Jan; 21(1):77-84. PubMed ID: 11149671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.
    Doods HN; Wienen W; Entzeroth M; Rudolf K; Eberlein W; Engel W; Wieland HA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):136-42. PubMed ID: 7562541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the combined ETA and ETB receptor antagonist PD145065 on arteries, arterioles, and veins in the cat hindlimb.
    Ekelund U; Adner M; Edvinsson L; Mellander S
    J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S211-3. PubMed ID: 8587365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of endothelium-derived nitric oxide in the regulation of tonus in large-bore arterial resistance vessels, arterioles and veins in cat skeletal muscle.
    Ekelund U; Mellander S
    Acta Physiol Scand; 1990 Nov; 140(3):301-9. PubMed ID: 2082699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ability of neuropeptide Y to mediate responses in the murine cutaneous microvasculature: an analysis of the contribution of Y1 and Y2 receptors.
    Chu DQ; Cox HM; Costa SK; Herzog H; Brain SD
    Br J Pharmacol; 2003 Sep; 140(2):422-30. PubMed ID: 12970079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microcirculatory dynamics of neuropeptide Y.
    Kim D; Durán WR; Kobayashi I; Daniels AJ; Durán WN
    Microvasc Res; 1994 Jul; 48(1):124-34. PubMed ID: 7990718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM; Modin A
    Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.